Skip to main content

Table 3 Overall response

From: Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer

Best response nab-PTX plus RAM PTX plus RAM P value
N = 83 % N = 106 %
CR 0 0 0 0  
PR 28 33.7 29 27.4
SD 40 48.2 42 39.6
PD 11 13.3 28 26.4
NE 4 4.8 7 6.6
ORR 28 33.7 29 27.4 0.385
DCR 68 81.9 71 67 0.016
  1. nab-PTX nanoparticle albumin-bound paclitaxel, RAM ramucirumab, CR complete response, PR partial response, SD stable disease, PD progressive disease, NE not evaluated, ORR overall response rate, DCR disease control rate
\